900000000000508004: Great Britain English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\GB English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
GB English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
pT2 stage	Acceptable (foundation metadata concept)
pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin)	Preferred (foundation metadata concept)
pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin) (finding)	Preferred (foundation metadata concept)
pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma)	Preferred (foundation metadata concept)
pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma) (finding)	Preferred (foundation metadata concept)
pT2: Organ confined (prostate)	Preferred (foundation metadata concept)
pT2: Organ confined (prostate) (finding)	Preferred (foundation metadata concept)
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm (liver, including intrahepatic bile ducts) (finding)	Preferred (foundation metadata concept)
pT2: Solitary tumour with vascular invasion or multiple tumours none more than 5 cm (liver, including intrahepatic bile ducts)	Preferred (foundation metadata concept)
pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus) (finding)	Preferred (foundation metadata concept)
pT2: Tumor confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma) (finding)	Preferred (foundation metadata concept)
pT2: Tumor extends to the soft tissues (nasopharynx) (finding)	Preferred (foundation metadata concept)
pT2: Tumor extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis) (finding)	Preferred (foundation metadata concept)
pT2: Tumor extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis) (finding)	Preferred (foundation metadata concept)
pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma) (finding)	Preferred (foundation metadata concept)
pT2: Tumor invades beyond the wall of bile duct (extrahepatic bile ducts) (finding)	Preferred (foundation metadata concept)
pT2: Tumor invades duodenal wall (ampulla of Vater) (finding)	Preferred (foundation metadata concept)
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx) (finding)	Preferred (foundation metadata concept)
pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx (finding)	Preferred (foundation metadata concept)
pT2: Tumor invades muscularis (renal pelvis and ureter) (finding)	Preferred (foundation metadata concept)
pT2: Tumor invades muscularis propria (appendix) (finding)	Preferred (foundation metadata concept)
pT2: Tumor invades muscularis propria (colon/rectum) (finding)	Preferred (foundation metadata concept)
pT2: Tumor invades muscularis propria (esophagus) (finding)	Preferred (foundation metadata concept)
pT2: Tumor invades muscularis propria (small intestine) (finding)	Preferred (foundation metadata concept)
pT2: Tumor invades muscularis propria (urinary bladder, ureter, renal pelvis) (finding)	Preferred (foundation metadata concept)
pT2: Tumor invades muscularis propria or subserosa (stomach) (finding)	Preferred (foundation metadata concept)
pT2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver (gallbladder) (finding)	Preferred (foundation metadata concept)
pT2: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion (nasal cavity and ethmoid sinus) (finding)	Preferred (foundation metadata concept)
pT2: Tumor involves any of the ipsilateral pleural surfaces with at least one of the following: confluent visceral pleural tumor (including fissure), invasion of diaphragmatic muscle, invasion of lung parenchyma (thoracic mesothelioma) (finding)	Preferred (foundation metadata concept)
pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension (exocrine pancreas) (finding)	Preferred (foundation metadata concept)
pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis (testis) (finding)	Preferred (foundation metadata concept)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (lip and oral cavity) (finding)	Preferred (foundation metadata concept)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (oropharynx) (finding)	Preferred (foundation metadata concept)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid) (finding)	Preferred (foundation metadata concept)
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands) (finding)	Preferred (foundation metadata concept)
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (anal canal) (finding)	Preferred (foundation metadata concept)
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (breast) (finding)	Preferred (foundation metadata concept)
pT2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)	Preferred (foundation metadata concept)
pT2: Tumor more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)	Preferred (foundation metadata concept)
pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney (kidney) (finding)	Preferred (foundation metadata concept)
pT2: Tumor more than 8 cm in greatest dimension (bone) (finding)	Preferred (foundation metadata concept)
pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)	Preferred (foundation metadata concept)
pT2: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung) (finding)	Preferred (foundation metadata concept)
pT2: Tumour > 2 cm but <= 5 cm in greatest dimension (breast)	Acceptable (foundation metadata concept)
pT2: Tumour causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus)	Preferred (foundation metadata concept)
pT2: Tumour confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma)	Preferred (foundation metadata concept)
pT2: Tumour extends to the soft tissues (nasopharynx)	Preferred (foundation metadata concept)
pT2: Tumour extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis)	Preferred (foundation metadata concept)
pT2: Tumour extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis)	Preferred (foundation metadata concept)
pT2: Tumour greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma)	Preferred (foundation metadata concept)
pT2: Tumour invades beyond the wall of bile duct (extrahepatic bile ducts)	Preferred (foundation metadata concept)
pT2: Tumour invades duodenal wall (ampulla of Vater)	Preferred (foundation metadata concept)
pT2: Tumour invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx)	Preferred (foundation metadata concept)
pT2: Tumour invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx	Preferred (foundation metadata concept)
pT2: Tumour invades muscularis (renal pelvis and ureter)	Preferred (foundation metadata concept)
pT2: Tumour invades muscularis propria (appendix)	Preferred (foundation metadata concept)
pT2: Tumour invades muscularis propria (colon/rectum)	Preferred (foundation metadata concept)
pT2: Tumour invades muscularis propria (oesophagus)	Preferred (foundation metadata concept)
pT2: Tumour invades muscularis propria (small intestine)	Preferred (foundation metadata concept)
pT2: Tumour invades muscularis propria (urinary bladder, ureter, renal pelvis)	Preferred (foundation metadata concept)
pT2: Tumour invades muscularis propria or subserosa (stomach)	Preferred (foundation metadata concept)
pT2: Tumour invades perimuscular connective tissue; no extension beyond serosa or into liver (gallbladder)	Preferred (foundation metadata concept)
pT2: Tumour invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion (nasal cavity and ethmoid sinus)	Preferred (foundation metadata concept)
pT2: Tumour involves any of the ipsilateral pleural surfaces with at least one of the following: confluent visceral pleural tumour (including fissure), invasion of diaphragmatic muscle, invasion of lung parenchyma (thoracic mesothelioma)	Preferred (foundation metadata concept)
pT2: Tumour limited to the pancreas, more than 2 cm in greatest dimension (exocrine pancreas)	Preferred (foundation metadata concept)
pT2: Tumour limited to the testis and epididymis with vascular/lymphatic invasion, or tumour extending through the tunica albuginea with involvement of the tunica vaginalis (testis)	Preferred (foundation metadata concept)
pT2: Tumour more than 2 cm but not more than 4 cm in greatest dimension (lip and oral cavity)	Preferred (foundation metadata concept)
pT2: Tumour more than 2 cm but not more than 4 cm in greatest dimension (oropharynx)	Preferred (foundation metadata concept)
pT2: Tumour more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid)	Preferred (foundation metadata concept)
pT2: Tumour more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands)	Preferred (foundation metadata concept)
pT2: Tumour more than 2 cm but not more than 5 cm in greatest dimension (anal canal)	Preferred (foundation metadata concept)
pT2: Tumour more than 2 cm but not more than 5 cm in greatest dimension (breast)	Preferred (foundation metadata concept)
pT2: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)	Preferred (foundation metadata concept)
pT2: Tumour more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumour/Ewing sarcoma)	Acceptable (foundation metadata concept)
pT2: Tumour more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma)	Preferred (foundation metadata concept)
pT2: Tumour more than 7 cm in greatest dimension, limited to the kidney (kidney)	Preferred (foundation metadata concept)
pT2: Tumour more than 8 cm in greatest dimension (bone)	Preferred (foundation metadata concept)
pT2: Tumour more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumour/Ewing sarcoma)	Acceptable (foundation metadata concept)
pT2: Tumour more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumour/Ewing's sarcoma)	Preferred (foundation metadata concept)
pT2: Tumour of lung as per AJCC 6th Edition definition (lung)	Preferred (foundation metadata concept)
pT2: Tumour of lung as per American Joint Committee on Cancer 6th Edition definition (lung)	Acceptable (foundation metadata concept)
pT2a	Preferred (foundation metadata concept)
pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary)	Preferred (foundation metadata concept)
pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding)	Preferred (foundation metadata concept)
pT2a (IIA): Tumor involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube) (finding)	Preferred (foundation metadata concept)
pT2a (IIA): Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) (finding)	Preferred (foundation metadata concept)
pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) (finding)	Preferred (foundation metadata concept)
pT2a (IIA): Tumour involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube)	Preferred (foundation metadata concept)
pT2a (IIA): Tumour limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri)	Preferred (foundation metadata concept)
pT2a (IIA): Tumour without parametrial invasion (TNM category and FIGO stage) (uterine cervix)	Preferred (foundation metadata concept)
pT2a - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
pT2a category	Preferred (foundation metadata concept)
pT2a category (finding)	Preferred (foundation metadata concept)
pT2a1	Preferred (foundation metadata concept)
pT2a1 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
pT2a2	Preferred (foundation metadata concept)
pT2a2 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin)	Preferred (foundation metadata concept)
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) (finding)	Preferred (foundation metadata concept)
pT2a: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding)	Preferred (foundation metadata concept)
pT2a: Tumor confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma) (finding)	Preferred (foundation metadata concept)

Start Previous Page 12882 of 12901 Next End

Reference Sets

Reference set descriptor

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001112010	Great Britain English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001113017	GB English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001114011	Great Britain English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)